Pharmaxis Financial Statements From 2010 to 2025
Pharmaxis' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Pharmaxis' valuation are provided below:Pharmaxis does not presently have any trending fundamental ratios for analysis.
This module can also supplement various Pharmaxis Technical models . Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
Check Pharmaxis financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pharmaxis' main balance sheet or income statement drivers, such as , as well as many indicators such as . Pharmaxis financial statements analysis is a perfect complement when working with Pharmaxis Valuation or Volatility modules.
Pharmaxis |
Pharmaxis Company Return On Equity Analysis
Pharmaxis' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Pharmaxis Return On Equity | 0.21 |
Most of Pharmaxis' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Pharmaxis is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, Pharmaxis has a Return On Equity of 0.2098. This is 100.88% lower than that of the sector and significantly higher than that of the Return On Equity industry. The return on equity for all United States stocks is 167.68% lower than that of the firm.
Pharmaxis Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Pharmaxis's current stock value. Our valuation model uses many indicators to compare Pharmaxis value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Pharmaxis competition to find correlations between indicators driving Pharmaxis's intrinsic value. More Info.Pharmaxis is regarded third in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Pharmaxis' earnings, one of the primary drivers of an investment's value.Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Consideration for investing in Pharmaxis Pink Sheet
If you are still planning to invest in Pharmaxis check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Pharmaxis' history and understand the potential risks before investing.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |